Overview of ViiV Healthcare Corporate Social Responsibility Programmes and Access to Medicines Strategy
ViiV Healthcare is committed to developing meaningful partnerships with relevant stakeholders in order to ensure access to important medicines and to elevating HIV care and resources in the communities where they are most needed.
Below you will find booklets which provide a succinct overview of programmes and initiatives supported by ViiV Healthcare across the world:
Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971 medsafety@hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
▼ These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Tivicay & Triumeq is registered trademark of the GlaxoSmithKline Group of Companies.
